Associations of microvascular complications with the risk of cardiovascular disease in type 1 diabetes
Gubitosi-Klug R, Gao X, Pop-Busui R, et al.
Diabetes Care. 2021;dc203104.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study
Chen Y, Zhang P, Wang J, et al.
Diabetologia 2021;64:1279-87.
Leggi
Usefulness of sodium-glucose cotransporter 2 inhibitors for primary prevention of heart failure in patients with type 2 diabetes mellitus
Arbel R, Aboalhasan E, Hammerman A, Azuri J
Am J Cardiol. Pub. online 15 May 2021
Leggi
Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
Syn NL, Cummings DE, Wang LZ, et al.
Lancet. 2021;S0140-6736(21)00591-2.
Leggi
Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
Cherney DZI, Charbonnel B, Cosentino F, et al.
Diabetologia 2021;64:1256-67.
Leggi
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
O’Donoghue ML, Kato ET, Mosenzon O, et al.
Diabetologia. 2021;64:1226-34.
Leggi
Continuous glucose monitoring Time-in-Range and HbA1c targets in pregnant women with type 1 diabetes
Tundindor D, Meek C, Yamamoto JM, et al.
Diabetes Technol Ther. Pub. online 4 May 2021
Leggi
Cigarette smoking as a predictor of sodium–glucose cotransporter 2 inhibitor–associated genital infections: a retrospective cohort study
Scoccimarro D, Cipani G, Dicembrini I, Mannucci E
Diabetes Care. 2021;dc210308
Leggi
High burden of subclinical and cardiovascular disease risk in adults with metabolically healthy obesity: the Atherosclerosis Risk in Communities (ARIC) study
Commodore-Mensah Y, Lazo M, Tang O, et al.
Diabetes Care. 2021;dc202227
Leggi
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: results from the CREDENCE trial and meta-analysis
Zhou Z, Jardine MJ, Li Q, et al.
Stroke. 2021;52(5):1545-1556
Leggi